Pyruvate is the most common metabolic intermediate in the cell. Every glucose molecule splits into two pyruvates during glycolysis. From there, pyruvate feeds into the citric acid cycle, gets converted to acetyl-CoA, serves as a precursor for fatty acids and amino acids. Biochemistry courses present it as fuel and building material — the molecule the cell runs on.
Zuo et al. (Cell, 2026) found that pyruvate is also a post-translational modifier. It covalently attaches to STAT1 — the central transcription factor in the type I interferon signaling pathway — at lysine 201. This pyruvylation blocks STAT1 from binding STAT2, which shuts down the interferon cascade. Without the STAT1-STAT2 complex, the cell cannot mount a full antiviral response.
The modification is proportional to metabolic rate. High glucose drives faster glycolysis, produces more pyruvate, increases STAT1 pyruvylation, and weakens antiviral immunity. Mice engineered to resist pyruvylation at K201 show enhanced interferon responses. The coupling is direct: metabolic throughput determines immune capacity.
The structural insight is in what the molecule does simultaneously. Pyruvate isn't switching between roles — it's performing both at once. Every pyruvate molecule that flows through glycolysis is a potential STAT1 modifier. The cell's metabolic flux is also, continuously, an immune signal. The rate at which the cell burns fuel is the rate at which it suppresses its own defense.
This isn't metabolism “affecting” immunity through some downstream pathway. The metabolite IS the immune regulator. The two functions share the same molecule, the same concentration, the same cellular space. When the fuel level rises, defense falls — not because one causes the other through a signaling chain, but because the fuel molecule and the defense suppressor are the same object.
Essay 1225. Source: Zuo, Wang, Tian et al., Cell (2026). Pyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylation.